T-bet is essential for encephalitogenicity of both Th1 and Th17 cells

被引:224
作者
Yang, Yuhong [2 ]
Weiner, Jeffrey [2 ]
Liu, Yue [1 ,2 ]
Smith, Alan J. [1 ]
Huss, David J. [1 ]
Winger, Ryan [2 ]
Peng, Haiyan [2 ]
Cravens, Petra D. [3 ]
Racke, Michael K. [2 ]
Lovett-Racke, Amy E. [1 ]
机构
[1] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[2] Ohio State Univ, Med Ctr, Dept Neurol, Columbus, OH 43210 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; INTERFERON-GAMMA; TRANSCRIPTION FACTOR; IFN-GAMMA; HELPER TYPE-1; TGF-BETA;
D O I
10.1084/jem.20082584
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The extent to which myelin-specific Th1 and Th17 cells contribute to the pathogenesis of experimental autoimmune encephalomyelitis (EAE) is controversial. Combinations of interleukin (IL)-1 beta, IL-6, and IL-23 with transforming growth factor beta were used to differentiate myelin-specific T cell receptor transgenic T cells into Th17 cells, none of which could induce EAE, whereas Th1 cells consistently transferred disease. However, IL-6 was found to promote the differentiation of encephalitogenic Th17 cells. Further analysis of myelin-specific T cells that were encephalitogenic in spontaneous EAE and actively induced EAE demonstrated that T-bet expression was critical for pathogenicity, regardless of cytokine expression by the encephalitogenic T cells. These data suggest that encephalitogenicity of myelin-specific T cells appears to be mediated by a pathway dependent on T-bet and not necessarily pathway-specific end products, such as interferon gamma and IL-17.
引用
收藏
页码:1549 / 1564
页数:16
相关论文
共 57 条
[1]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[2]   T-CELLS RESPONSIVE TO MYELIN BASIC-PROTEIN IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
ALLEGRETTA, M ;
NICKLAS, JA ;
SRIRAM, S ;
ALBERTINI, RJ .
SCIENCE, 1990, 247 (4943) :718-721
[3]   ENCEPHALITOGENIC T-CELLS IN THE B10.PL MODEL OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE) ARE OF THE TH-1 LYMPHOKINE SUBTYPE [J].
ANDO, DG ;
CLAYTON, J ;
KONO, D ;
URBAN, JL ;
SERCARZ, EE .
CELLULAR IMMUNOLOGY, 1989, 124 (01) :132-143
[4]   Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis [J].
Bettelli, E ;
Sullivan, B ;
Szabo, SJ ;
Sobel, RA ;
Glimcher, H ;
Kuchroo, VK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) :79-87
[5]  
Betti M, 2006, ANN ONCOL, V17, P235
[6]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[7]  
Burns J, 1999, ANN NEUROL, V45, P33, DOI 10.1002/1531-8249(199901)45:1<33::AID-ART7>3.3.CO
[8]  
2-7
[9]   The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease [J].
Chabas, D ;
Baranzini, SE ;
Mitchell, D ;
Bernard, CCA ;
Rittling, SR ;
Denhardt, DT ;
Sobel, RA ;
Lock, C ;
Karpuj, M ;
Pedotti, R ;
Heller, R ;
Oksenberg, JR ;
Steinman, L .
SCIENCE, 2001, 294 (5547) :1731-1735
[10]   Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis [J].
Chen, Y ;
Langrish, CL ;
Mckenzie, B ;
Joyce-Shaikh, B ;
Stumhofer, JS ;
McClanahan, T ;
Blumenschein, W ;
Churakovsa, T ;
Low, J ;
Presta, L ;
Hunter, CA ;
Kastelein, RA ;
Cua, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1317-1326